Searchable abstracts of presentations at key conferences in endocrinology

ea0029s35.2 | Endocrinology and the Olympics: Will hormones help to win? | ICEECE2012

Can an endocrine patient participate in high performance sports?

Auchus R. , Brenna J. , Tobias H. , Zhang Y.

The question posed by this title encompasses three issues. First, certain endocrine diseases present physiologic challenges to high-intensity or endurance activities, including type 1 diabetes mellitus and adrenal insufficiency. Using carefully adjusted insulin regimens evolved in concert with training sessions, several athletes with type 1 diabetes have succeeded in elite competitions, but the endocrinologist must ‘train with the athlete’ and craft regimens that con...

ea0029p1217 | Obesity | ICEECE2012

Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in chinese young adults

Shi J. , Hong J. , Gu W. , Zhang Y. , Cui B. , Yan Q. , Wang W. , Ning G.

Clear evidence on the specific impact of fatty acid binding proteins (FABPs) on cell biology and lipid metabolism in complex systems had been lacking until FABP-deficient mice models were created. Surprisingly, no change in appearance, gross morphology or viability was observed in FABP1-deficient mice. However, metabolic parameters in mice upon exposure to high-fat/cholesterol diet differed between studies. Therefore, liver fatty acid-binding protein (also called FABP1) plays ...

ea0029p1542.1 | Pituitary Clinical | ICEECE2012

Evaluation of the efficacy and safety of pasireotide LAR in patients with mild-to-moderate cushing’s disease: a randomized, double-blind, multicenter, phase III study design

Ligueros-Saylan M. , Zhang Y. , Newell-Price J. , Petersenn S. , Lymperopoulos S.

Background: Cushing’s disease is associated with high morbidity and mortality, and there are currently no approved medical therapies. Twice-daily pasireotide sc showed efficacy in patients with mostly moderate-to-severe (UFC≥2×ULN) Cushing’s disease in a large, randomized, double-blind, 12-month trial. A monthly long-acting release (LAR) formulation of pasireotide has been developed to provide a smoother pharmacokinetic profile, potentially a better effica...

ea0029oc1.2 | Pituitary Clinical I | ICEECE2012

Patients with Cushing’s disease achieve normal urinary cortisol with LCI699, a potent 11β-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study

Bertagna X. , Pivonello R. , Fleseriu M. , Zhang Y. , Robinson P. , Taylor A. , Watson C. , Maldonado M. , Hamrahian A. , Boscaro M. , Biller B.

Introduction: The clinical features and complications of Cushing’s syndrome result from chronic excess of circulating cortisol, typically quantified by 24-h urinary free cortisol (UFC). LCI699 is a potent inhibitor of 11β-hydroxylase. Since 11β-hydroxylase catalyzes the final step of cortisol synthesis, LCI699 is a potential new treatment for all forms of Cushing’s syndrome.Methods: Adult patients with mild-to-severe Cushing’s di...

ea0029oc3.3 | Diabetes Clinical | ICEECE2012

Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes

Gu W. , Hu J. , Zhu D. , Tang W. , Li L. , Cui W. , Hong J. , Zhang Y. , Wang W. , Ning G.

Objective: To determine if autologous nonmyeloablative hematopoietic stem cell transplantation (AHSCT) was worthwhile to do in type 1 diabetes adolescents with diabetic ketoacidosis at diagnosis.Research Design and Methods: We enrolled 28 type 1 diabetes patients aged 14–30 years in a prospective AHSCT phase II clinical trial. Hematopoietic stem cells were harvested from the peripheral blood following a pretreatment consisting of a combination of cy...

ea0083ao2 | Adrenal and Cardiovascular | EYES2022

Combining steroid and global metabolome profiling by mass spectrometry with machine learning to investigate metabolic risk in benign adrenal tumours with mild autonomous cortisol secretion

A Prete , L Abdi , M Canducci , A. E. Taylor , L. C. Gilligan , A Albors-Zumel , E van den Brandhof , Y Zhang , K. N. Manolopoulos , P Tino , M Biehl , W. B. Dunn , W Arlt

Background: Benign adrenal tumours are discovered in 3-10% of adults and can be non-functioning (NFAT) or associated with adrenal hormone excess, most frequently mild autonomous cortisol secretion (MACS) defined by the failure to suppress cortisol after 1 mg dexamethasone overnight but lack of distinct signs of Cushing’s syndrome (CS). We found that MACS increases the prevalence and severity of type 2 diabetes and hypertension and primarily affects women (Ann Int Med. 202...

ea0029oc12.4 | Obesity Clinical | ICEECE2012

Genetic susceptibility, birth weight and obesity risk in young chinese

Shi J. , Hong J. , Qi L. , Cui B. , Gu W. , Zhang Y. , Li L. , Xu M. , Wang L. , Zhai Y. , Miao L. , Wang R. , Bi Y. , Wang W. , Ning G.

Thus far, approximately 30 loci influencing body mass index (BMI) and the risk of obesity have been identified. In this study, we aimed to examine the individual and joint associations of 23 BMI-associated loci identified from recent genome-wide association studies in Caucasians with obesity risk in young Chinese. Birth weight reflects prenatal metabolic adaption and has been related to later-life obesity risk. We particularly assessed whether these genetic variants interacted...